Immucell (ICCC) Invested Capital (2010 - 2026)
Immucell's (ICCC) quarterly Invested Capital came in at $1.6 million in Q4 2025, up 7.52% YoY from $1.5 million in Q4 2024, and up 1.15% on a QoQ basis from $1.6 million in Q3 2025.
Immucell (ICCC) Invested Capital (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Invested Capital data on file, last reported at $1.6 million in Q4 2025.
- Quarterly Invested Capital rose 7.52% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.3 million (up 6.32% YoY) and the FY2025 annual result came in at $1.6 million, up 7.52% from the prior year.
- Invested Capital improved to $1.6 million in Q4 2025, from $1.6 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $1.6 million in Q4 2025 to a low of $767517.0 in Q1 2021.
- A 5-year average of $1.2 million and a median of $1.2 million in 2022 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2021 — Invested Capital declined 25.84% — and 2024, when it soared 46.12%.
- Tracing ICCC's Invested Capital over 5 years: stood at $812207.0 in 2021, then advanced by 27.98% to $1.0 million in 2022, then surged by 37.46% to $1.4 million in 2023, then rose by 4.82% to $1.5 million in 2024, then climbed by 7.52% to $1.6 million in 2025.
- The last three Invested Capital figures came in at $1.6 million (Q4 2025), $1.6 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Immucell | 91.19 Mn | 82.33 Mn | 2.44 Mn | 1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.51 Mn |
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 1.54 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 1.43 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 998,160.00 |
| Jun 30, 2022 | 966,996.00 |
| Mar 31, 2022 | 947,279.00 |
| Dec 31, 2021 | 812,207.00 |
| Sep 30, 2021 | 782,525.00 |
| Jun 30, 2021 | 774,989.00 |